跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
安吉优 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Vedolizumab for injection
Approved
生物制品
Vedolizumab for injection
Takeda Pharma A/S
🇨🇳 National Medical Products Administration
Approval Date
Mar 11, 2020
Approval ID
7w10tc0dAnY
Company
Takeda Pharma A/S
Type
生物制品
Approval Details
Approval Id
7w10tc0dAnY
Approval Number
S20200006
Generic Name
注射用维得利珠单抗
Generic Name En
Vedolizumab for injection
Trade Name
安吉优
Drug Type
生物制品
Dosage Form
注射剂
Strength
300mg/瓶
Reg Date
2020-03-11
Expired Date
2025-03-10
Company Name
Takeda Pharma A/S
Company Address
Delta Park 45, 2665 Vallensbaek Strand, Denmark
Production Company Name
Takeda Pharmaceutical Company Ltd
Production Company Address
4720 Mitsui,Yamaguchi Prefecture,743-8502 Hikari,Japan
Company Detail Path
/organization/takeda-pharma-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 11, 2020
Approval ID
7w10tc0dAnY
Type
生物制品
Back to NMPA Approvals